⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Silicate SCHEMBL5028776 | 1.00 | — | — | |
| Silicate SCHEMBL5190971 | 1.00 | — | — | |
| Silicate SCHEMBL4730256 | 1.00 | — | — | |
| Silicate SCHEMBL8065814 | 1.00 | — | — | |
| Silicate SCHEMBL8009477 | 1.00 | — | — | |
| Silicate SCHEMBL9450176 | 1.00 | — | — | |
| Silicate SCHEMBL7874481 | 1.00 | — | — | |
| Silicate SCHEMBL4211043 | 1.00 | — | — | |
| Silicate SCHEMBL538885 | 1.00 | — | — | |
| Silicate SCHEMBL10390173 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11046950-B2 | Magnetic particles with a closed ultrathin silica layer, method for the production thereof and their use | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2021-06-29 | — | — | US | disclosed |
| US-10385331-B2 | Magnetic particles with a closed ultrathin silica layer, method for the production thereof and their use | SIEMENS HEALTHCARE DIAGNOSTICS GMBH (DE) | 2019-08-20 | — | — | US | disclosed |
| US-20190241885-A1 | Magnetic particles with a closed ultrathin silica layer, method for the production thereof and their use | SIEMENS HEALTHCARE DIAGNOSTICS GMBH (DE) | 2019-08-08 | — | — | US | disclosed |
| US-20170159043-A1 | Magnetic particles with a closed ultrathin silica layer, method for the production thereof and their use | SIEMENS HEALTHCARE DIAGNOSTICS GMBH (DE) | 2017-06-08 | — | — | US | disclosed |
| US-9617534-B2 | Magnetic particles with a closed ultrathin silica layer, method for the production thereof and their use | SIEMENS HEALTHCARE DIAGNOSTICS GMBH (DE) | 2017-04-11 | — | — | US | disclosed |
| EP-2125659-B1 | SILICA MAGNETIC PARTICLES WITH A HIGH NUCLEIC ACID BINDING CAPABILITY | SIEMENS HEALTHCARE DIAGNOSTICS (US) | 2016-01-13 | — | — | EP | disclosed |
| US-20150191718-A1 | Magnetic particles with a closed ultrathin silica layer, method for the production thereof and their use | SIEMENS HEALTHCARE DIAGNOSTICS GMBH (DE) | 2015-07-09 | — | — | US | disclosed |
| US-8323899-B2 | Silica magnetic particles with a high nucleic acid binding capacity | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2012-12-04 | — | — | US | disclosed |
| US-20100063263-A1 | Magnetic particles with a closed ultrathin silica layer, method for the production thereof and their use | SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS GMBH (DE) | 2010-03-11 | — | — | US | disclosed |
| US-20100009375-A1 | Silica Magnetic Particles with a High Nucleic Acid Binding Capacity | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2010-01-14 | — | — | US | disclosed |
| EP-2125659-A2 | SILICA MAGNETIC PARTICLES WITH A HIGH NUCLEIC ACID BINDING CAPABILITY | Siemens Healthcare Diagnostics Inc. (US) | 2009-12-02 | — | — | EP | disclosed |
| US-7612137-B2 | Surface-modified silica gels | DEGUSSA AG (DE) | 2009-11-03 | — | — | US | disclosed |
| US-20080299491-A1 | HIGHLY ALKALINE DEVELOPER COMPOSITION AND METHODS OF USE | EASTMAN KODAK COMPANY | 2008-12-04 | — | — | US | disclosed |
| WO-2008095155-A2 | SILICA MAGNETIC PARTICLES WITH A HIGH NUCLEIC ACID BINDING CAPABILITY | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2008-08-07 | — | — | WO | disclosed |
| US-20050282934-A1 | Surface-modified silica gels | DEGUSSA AG (DE) | 2005-12-22 | — | — | US | disclosed |